FilingReader Intelligence

Dalian Bio-Chem responds to inquiry on 2024 annual report

July 4, 2025 at 11:29 AM UTCBy FilingReader AI

Dalian Bio-Chem has released a detailed response to the Shanghai Stock Exchange's inquiry regarding its 2024 annual report, addressing key areas of concern. Regarding its industrial bactericide business, where sales grew to CNY 1.207 billion and accounted for 92% of revenue, the company provided a breakdown of product pricing, sales volume, and cost analysis, attributing margin changes to market competition and demand shifts. The company also disclosed information on its top international clients.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:603360Shanghai Stock Exchange

News Alerts

Get instant email alerts when Dalian Bio-Chem publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →